Pharmeuropa: Revised Chapter 2.9.1. "Disintegration of tablets and capsules" published for comment
Recommendation
Wednesday, 1 October 2025 13.00 - 17.00 h
Register now for ECA's GMP Newsletter
In the Pharmeuropa issue 35.2, a proposal for a revised chapter 2.9.1 "Disintegration of tablets and capsules" was published. The deadline for submitting comments is 30 June 2023.
The test of disintegration is provided to determine whether tablets or capsules disintegrate within the prescribed time when placed in a liquid medium under the experimental conditions presented in the chapter.
According to the briefing notes, compared to the monograph published in the 11th Edition of the Ph. Eur., the following changes are proposed:
- "Test B (intended for tablets and capsules larger than 18 mm) has been harmonised.
- A reference to ISO and ASTM standards has been added for the low-form beaker.
- An additional requirement for the inner diameter of the beaker used for Test B has been introduced.
- The general chapter also now explicitly allows the use of automatic disintegration detection instruments."
The full text and further details on the revision and can be found, after registration, on the Pharmeuropa website.
Related GMP News
30.06.2025FDA Warning Letter: Missing Testing, No Stability Data, and Inadequate Raw Material Controls
25.06.2025FDA Warning Letter: "Memory-Based Manufacturing" and Lack of Analytical Testing
11.06.2025USP informs about Monographs affected by the Revision of NMR Chapters <761> and <1761>
28.05.2025FDA Warning Letter for Chinese Manufacturer: Inadequate Testing and Stability Program Deficiencies